Relative Importance of Quantifying Area and Vascular Patterns in Uveal Melanomas

https://doi.org/10.1016/S0002-9394(14)71129-8Get rights and content

Purpose

To test whether the cross-sectional area of choroidal and ciliary body melanomas and quantification of microcirculatory networks and parallel vessels with cross-linking are features associated with death from metastatic melanoma, and to compare new with conventional histologic prognostic features.

Methods

The cross-sectional area of 234 ciliary body or choroidal melanomas was measured from digitized images of histologic sections. The percentage of cross-sectional area occupied by two microcirculatory patterns---networks and parallel vessels with cross-linking---was calculated for the 152 tumors containing at least one focus of either pattern. Kaplan-Meier survival curves were generated based on cross-sectional and percentage of cross-sectional areas of these patterns. Cox proportional hazard regression methods related time to death from melanoma with sets of predictor variables. For each model, percent variation explained was computed.

Results

Patient survival differs significantly when tumors are classified based on cross-sectional area: small (< 16 mm2), medium (≥ 16 mm2 but < 61.4 mm2), and large (≥ 61.4 mm2). Patients with tumors containing networks and parallel vessels with cross-linking microcirculation patterns that occupy 2% of cross-sectional area have a significantly worse prognosis than do those patients with tumors containing a smaller percentage of these patterns.

Conclusions

Quantifying cross-sectional tumor area and the percentage area occupied by networks and parallel vessels with cross-linking microcirculatory patterns in ciliary body and choroidal melanomas provides significant prognostic information. Compared with more conventional prognostic characteristics, the most dramatic increase in prognostic information is provided by determination of the presence or absence of micro-vascular patterns.

REFERENCES (53)

  • RummeltV et al.

    Microcirculation architecture of melanocytic nevi and malignant melanomas of the ciliary body and choroid: a comparative histopathologic and ultrastructural study

    Ophthalmology

    (1994)
  • SakamotoT et al.

    Histologic findings and prognosis of uveal malignant melanoma in Japanese patients

    Am J Ophthalmol

    (1996)
  • BartschD et al.

    Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography

    Am J Ophthalmol

    (1995)
  • ColemanDJ et al.

    Correlations of acoustic tissue typing of malignant melanoma and histopathologic features as a predictor of death

    Am J Ophthalmol

    (1990)
  • FeleppaEJ et al.

    Diagnostic spectrum analysis in ophthalmology: a physical perspective

    Ultrasound Med Biol

    (1986)
  • FalkP

    Differences in vascular pattern between the spontaneous and the transplanted C3H mouse mammary carcinoma

    Eur J Cancer Clin Oncol

    (1982)
  • ShammasHF et al.

    Prognostic factors in choroidal and ciliary body melanomas

    Arch Ophthalmol

    (1977)
  • McLeanIW et al.

    Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis

    Hum Pathol

    (1982)
  • SeddonJM et al.

    A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma

    Arch Ophthalmol

    (1983)
  • FolbergR et al.

    Comparison of direct and microslide pathology measurements of uveal melanomas

    Invest Ophthalmol Vis Sci

    (1985)
  • GamelJW et al.

    A clinically useful method for combining gross and microscopic measurements to select high-risk patients after enucleation for ciliochoroidal melanoma

    Cancer

    (1986)
  • de la CruzPO et al.

    Lymphocytic infiltration in uveal malignant melanoma

    Cancer

    (1990)
  • GamelJW et al.

    A comparison of prognostic covariates for uveal melanoma

    Invest Ophthalmol Vis Sci

    (1992)
  • AppleDJ et al.

    Uveal melanocytic tumors: a grouping according to phases of growth and prognosis with comments on current theories of non-enucleation

    Int Ophthalmol Clin

    (1980)
  • KalbfleischJ et al.
  • SAS technical report P-229, SAS/STAT software: changes and enhancements. Release 6.07. Cary, North Carolina: SAS...
  • Cited by (31)

    • OCT Angiography: Imaging of Choroidal and Retinal Tumors

      2018, Ophthalmology Retina
      Citation Excerpt :

      According to histopathologic studies, chorioretinal tumors have specific vascular patterns and characteristics8–10 (Table 1).

    • Malignant melanoma in the 21st century, part 2: Staging, prognosis, and treatment

      2007, Mayo Clinic Proceedings
      Citation Excerpt :

      How this is related to metastasis is still unknown. More recent studies have shown that periodic acid-Schiff-positive loops are a separate independent risk factor for the development of metastasis.221 These loops have been shown to be vascular loops that consist of a combination of endothelial cells and tumor cells.

    • Tumor cell plasticity in uveal melanoma: Microenvironment directed dampening of the invasive and metastatic genotype and phenotype accompanies the generation of vasculogenic mimicry patterns

      2006, American Journal of Pathology
      Citation Excerpt :

      Therefore, relative successes in treating planktonic malignancies such as the leukemias compared with solid malignancies may be related in part to the generation of vasculogenic mimicry patterns now documented3 in a wide variety of solid cancers. It is possible that in some tumors, highly invasive melanoma cells do not generate vasculogenic mimicry patterns or the patterns form only focally (vasculogenic mimicry patterns tend to form in discrete zones, typically at the tumor periphery at the interface between the tumor and the surrounding stroma56 and only seldom encompass the entire tumor57). Therefore, highly invasive tumor cells spatially remote from vasculogenic mimicry patterning may contribute to metastatic behavior.

    View all citing articles on Scopus

    This study was supported by grant EY10457, National Institutes of Health (Dr Folberg), and in part by an unrestricted grant from Research to Prevent Blindness, Inc, New York, New York.

    Reprint requests to Robert Folberg, MD, University of Iowa, 100 Medical Research Center, Rm 233, Iowa City, IA 52242-1182; fax: (319) 335-7193; e-mail: [email protected]

    View full text